Identifying Biomarkers and Drug Targets for Liver Cancer
Author Information
Author(s): Rahman Md. Okibur, Das Asim, Naeem Nazratun, Jabeen-E-Tahnim, Hossain Md. Ali, Alam Md. Nur, Azad AKM, Alyami Salem A., Alotaibi Naif, Al-Moisheer A. S., Moni Mohammod Ali, Li Chia-Jung, Meng Xiangbing
Primary Institution: Department of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh
Hypothesis
This study aims to identify prognostic biomarkers and therapeutic targets for hepatocellular carcinoma (HCC) using integrated bioinformatics approaches.
Conclusion
The study identified several hub genes and transcription factors that could serve as valuable prognostic biomarkers and therapeutic targets for HCC.
Supporting Evidence
- 176 common differentially expressed genes were identified from two microarray datasets.
- 12 hub genes were found to be significantly overexpressed in HCC patients.
- Survival analyses indicated that 11 hub genes are linked to poor patient survival.
Takeaway
Researchers found important genes that can help doctors predict how bad liver cancer will be and suggest new medicines to treat it.
Methodology
The study used integrated bioinformatics approaches, including differential expression analysis, functional enrichment analysis, and molecular docking.
Limitations
The study primarily relies on bioinformatics data, which may require experimental validation.
Participant Demographics
The study analyzed data from patients with hepatocellular carcinoma and healthy controls.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website